Table:
text: Adeno-associated virus
Clinical trials
Selected Clinical Trials using AAV-Based Vectors
Gene Route_of_administration Phase Subject_number Status_
CFTR Lung, via aerosol I 12 Complete
CFTR Lung, via aerosol II 38 Complete
CFTR Lung, via aerosol II 100 Complete
FIX Intramuscular I 9 Complete
FIX Hepatic artery I 6 Ended
TNFR:Fc Intraarticular I 1 Ongoing
AAT Intramuscular I 12 Ongoing
RPE65 Subretinal I-II Multiple Several ongoing and complete
sFlt-1 Subretinal I-II 24 Ongoing
Sarcoglycan Intramuscular I 10 Ongoing
GAD65, GAD67 Intracranial I 12 Complete
AAC Intracranial I 21 Ongoing
CLN2 Intracranial I 10 Ongoing
NGF Intracranial I 6 Ongoing

Question: Which gene is underway and has an intramuscular route of administration in adeno-associated virus?

Question: Which adeno-associated virus gene has subject number 21?

Question: What is the route of administration that has multiple persistent and complete adeno-associated viruses?

Question: What is the status of the aat gene in adeno-associated viruses that have an intramuscular route of administration?